Live Breaking News & Updates on Plasma Derived Therapy

Stay updated with breaking news from Plasma derived therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Takeda's FY21 revenue gets boost from gastro dug Entyvio sales; provides FY22 outlook

Takeda's FY21 revenue grows on the back of gastroenterology portfolio and the Japanese company provided outlook for FY22.Core EPS grew +9.4% Y/Y to ¥425; while Core revenue increased. ....

Takeda Pharmaceutical Company , Takeda Pharmaceutical , Stock Editorial , Rare Hematology , Hereditary Angioedema , Plasma Derived Therapy , Emerging Markets , Operating Profit ,